The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

With new testing requirements, it’s not even clear how new Covid or flu shots can be made available this fall.

The Trump administration plans to drop routine COVID vaccination guidance for kids and pregnant women, marking a major shift ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

Seventy-five years of preparation for an outbreak like that of COVID-19—and yet, the Centers for Disease Control and ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

A vaccine designed to protect against chikungunya, a mosquito-borne illness, has been temporarily paused for individuals aged 60 and older.

The U.S. Department of Health and Human Services is planning to drop CDC recommendations for routine Covid-19 vaccines for ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.